Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Background and Objective: Dual antiplatelet therapy (DAPT) is the basis for preventing ischemic events after percutaneous coronary intervention (PCI), and DAPT for 12 months has been the standard strategy recommended by the guidelines. However, patients with acute coronary syndrome (ACS) have a high...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Peng-Yu Zhong, Yao-Sheng Shang, Nan Bai, Ying Ma, Ying Niu, Zhi-Lu Wang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-09-01
Edice:	Frontiers in Cardiovascular Medicine
Témata:	acute coronary syndrome percutaneous coronary intervention drug-eluting stents dual antiplatelet therapy trial sequential analysis
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.660360/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!